NCT06174259招募中不适用
Influence of Intermittent Fasting on Locally Advanced Breast Cancer Patients: a Prospective Randomized Controlled Trial
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 66
- 试验地点
- 2
- 主要终点
- pathological response rate
研究概览
简要总结
Breast cancer is the most common cancer type among women in Egypt and world. Preclinical studies show fasting reduces growth factors and modulates nutrient sensing systems, protecting normal cells against chemotherapy. However, cancer cells are not protected due to Differential Stress Resistance (DSR), making them more vulnerable to chemotherapeutics. This study aims to evaluate intermittent fasting impact on neoadjuvant chemotherapy in breast cancer patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Female patients with stage II or III (cT1cN+ or ≥T2 any cN, cM0) breast cancer. - Planned to receive standard neoadjuvant chemotherapy.
- •Measurable disease (breast and/or lymph nodes).
- •WHO performance status 0-
- •Being overweight (BMI: 25-29.9 kg/m2) or obese (BMI: ≥30 kg/m2).
- •Adequate bone marrow function : white blood cells (WBCs) ≥3.0 x 109/l, neutrophils ≥1.5 x 109/l, platelets ≥100 x 109/l
- •Adequate liver function: bilirubin ≤1.5 x upper limit of normal (UNL) range, ALAT and/or ASAT ≤2.5 x UNL, Alkaline Phosphatase ≤5 x UNL
- •Adequate renal function: the calculated creatinine clearance should be ≥50 mL/min
- •Patients must be accessible for treatment and follow-up
排除标准
- •Serious diseases such as recent myocardial infarction, clinical signs of cardiac failure or clinically significant arrhythmias
- •Diabetes Mellitus.
- •Pregnancy or lactating
- •Any metabolic disorders that may affect gluconeogenesis or adaptation to fasting periods.
- •Previous malignancy.
- •Using weight loss medication.
结局指标
主要结局
pathological response rate
时间窗: 6months
Assessment of pathological response using the Miller-Payne grading system; it is a grading system from 1-5 with 5 is the best response
次要结局
- Body composition changes (fat, muscles, water)(6 months)
- Inflammatory response to chemotherapy.(6 months)
- The percentage of patients with grade III/IV toxicity(6 months)
- Grade I/II side effects of chemotherapy(6 months)
- Clinical response(6months)
- Long term efficacy of treatment(5 years)
研究者
yostena nagy kamel mekhail
Dr
Menoufia University
研究点 (2)
Loading locations...
相似试验
撤回
不适用
The Effect of Intermittent Fasting on Body Composition in Women With Breast CancerBreast CancerNCT04691999Duke University
招募中
不适用
Time Restricted Eating During Chemotherapy for Breast CancerBreast Cancer FemaleNCT05259410University of Illinois at Chicago40
已完成
不适用
Diet Induced Weight Loss to Reduce Inflammation in Obese WomenObesityNCT01699906Rockefeller University22
招募中
不适用
Evaluating a Fasting-mimicking Diet in Combination With Immunotherapy in Patients With Non-small Cell Lung CancerStage IV NSCLCImmunotherapyFasting Mimicking DietNSCLCNCT06671613VA Office of Research and Development66
已完成
不适用
Influence of an Intervention on Diet, Physical Exercise and Mindfulness in the Quality of Life of Survivors With Breast CancerNutrition Related CancerPhysical ActivityMindfulnessBreast CancerNCT04150484Universidad de Granada67